A single infusion of infliximab increases the serum endostatin level in patients with rheumatoid arthritis.
E J
EJ
Kucharz
J
J
Gozdzik
M
M
Kopec
A
A
Kotulska
M
M
Lewicki
R
R
Pieczyrak
M
M
Widuchowska
H
H
Zakliczynska
M
M
Szarzynska-Ruda
E
E
Zycinska-Debska
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D003094:Collagen / Q000097:blood*; D043169:Endostatins; D005260:Female; D006801:Humans; D000069285:Infliximab; D007263:Infusions, Parenteral; D008875:Middle Aged; D009389:Neovascularization, Pathologic; D010446:Peptide Fragments / Q000097:blood*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D043169:Endostatins; D010446:Peptide Fragments; D003094:Collagen; D000069285:Infliximab